BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND BTK, AGMX1, 695, ENSG00000010671, XLA, IMD1, RP1-164F3_2, MGC126262, BPK, ATK, MGC126261, Q06187, AT, PSCTK1 AND Treatment
32311 results:

  • 1. [Adrenocortical cancer: late diagnosis of the disease on the example of a clinical case. Case report].
    Starostina EA; Molashenko NV; Levshina AR; Pachuashvili NV; Chevais A; Isaeva MP; Getazheev KV; Beltsevich DG; Platonova NM; Troshina EA
    Ter Arkh; 2023 Dec; 95(12):1179-1184. PubMed ID: 38785058
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Recurrent fever leading to the diagnosis of an angiosarcoma of the adrenal gland: a case report.
    Lederer AK; Zimmer S; Margies R; Krettek P; Musholt TJ
    J Med Case Rep; 2024 May; 18(1):258. PubMed ID: 38783354
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Highly variable biological effects of statins on cancer, non-cancer, and stem cells in vitro.
    Gbelcová H; Rimpelová S; Jariabková A; Macášek P; Priščáková P; Ruml T; Šáchová J; Kubovčiak J; Kolář M; Vítek L
    Sci Rep; 2024 May; 14(1):11830. PubMed ID: 38782983
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing therapeutics in RB1-deficient cancer cells.
    Bulanova D; Akimov Y; Senkowski W; Oikkonen J; Gall-Mas L; Timonen S; Elmadani M; Hynninen J; Hautaniemi S; Aittokallio T; Wennerberg K
    Sci Adv; 2024 May; 10(21):eadj1564. PubMed ID: 38781347
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pharmacogenomic analysis in adrenocortical carcinoma reveals genetic features associated with mitotane sensitivity and potential therapeutics.
    Zhang J; Wu L; Su T; Liu H; Jiang L; Jiang Y; Wu Z; Chen L; Li H; Zheng J; Sun Y; Peng H; Han R; Ning G; Ye L; Wang W
    Front Endocrinol (Lausanne); 2024; 15():1365321. PubMed ID: 38779454
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prophylactic central lymph node dissection in cN0 papillary thyroid cancer: a comparative study of via breast and transoral approach versus via breast approach alone.
    Qiu R; Fu J
    Front Endocrinol (Lausanne); 2024; 15():1356739. PubMed ID: 38774230
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Surgical outcomes of robotic thyroidectomy for thyroid tumors over 4 cm via the bilateral axillo-breast approach.
    Bae HL; Wong JS; Kim SJ; Jung Y; Choi JB; Kwak J; Yu HW; Chai YJ; Choi JY; Lee KE
    Sci Rep; 2024 May; 14(1):11646. PubMed ID: 38773181
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis.
    Liu Y; Shi W; Mubarik S; Wang F
    BMC Public Health; 2024 May; 24(1):1349. PubMed ID: 38764017
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Deciphering the progression of fine-needle aspiration: A bibliometric analysis of thyroid nodule research.
    Liu T; Yang F; Qiao J; Mao M
    Medicine (Baltimore); 2024 May; 103(20):e38059. PubMed ID: 38758913
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Palliative treatment of generalized metastatic follicular carcinoma of thyroid after operation: A case report and literature review.
    Zhao H; Kang W; Guan J; Wang Y
    Medicine (Baltimore); 2024 May; 103(20):e38237. PubMed ID: 38758843
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Current data and future perspectives on DNA methylation in ovarian cancer (Review).
    Fu M; Deng F; Chen J; Fu L; Lei J; Xu T; Chen Y; Zhou J; Gao Q; Ding H
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757340
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application.
    Zheng R; Liu X; Zhang Y; Liu Y; Wang Y; Guo S; Jin X; Zhang J; Guan Y; Liu Y
    Front Immunol; 2024; 15():1383978. PubMed ID: 38756774
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification.
    Huai M; Wang Y; Li J; Pan J; Sun F; Zhang F; Zhang Y; Xu L
    J Nanobiotechnology; 2024 May; 22(1):257. PubMed ID: 38755645
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian cancer: Findings From Cohort A of the OPAL Phase II Trial.
    Liu JF; Gaillard S; Wahner Hendrickson AE; Yeku O; Diver E; Gunderson Jackson C; Arend R; Ratner E; Samnotra V; Gupta D; Chung J; Zhang H; Compton N; Baines A; Bacqué E; Liu X; Felicetti B; Konecny GE
    JCO Precis Oncol; 2024 May; 8():e2300693. PubMed ID: 38754056
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Feasibility and cost-effectiveness of genetic counselling for all patients with newly diagnosed ovarian cancer: a single-centre retrospective study.
    Schlootz S; Saner FAM; Rabaglio M; Imboden S; Wampfler J
    Swiss Med Wkly; 2024 Apr; 154():3386. PubMed ID: 38754016
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Rare Columnar Cell Variant of Papillary Thyroid Carcinoma with Cervical Spine Metastasis: A Case Report.
    Yu J; Yang G; Oh HY; Ryu YJ
    Curr Med Imaging; 2024; 20(1):e15734056300884. PubMed ID: 38752631
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Trends and projections of the global burden of thyroid cancer from 1990 to 2030.
    Hu S; Wu X; Jiang H
    J Glob Health; 2024 May; 14():04084. PubMed ID: 38751316
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience.
    Sukrithan V; Armbruster H; Rogers S; Vogt SM; Grenade C; Verschraegen C; Zhou Y; Goyal A; Natwa M; Hussein A; Barr H; Konate D; Batdorf R; Brown A; Williams B; Zhao S; Wei L; Xu M; Shah MH; Konda B
    PLoS One; 2024; 19(5):e0298824. PubMed ID: 38748739
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer.
    Kim BG; Lee SH; Jang Y; Kang S; Kang CM; Cho NH
    J Transl Med; 2024 May; 22(1):453. PubMed ID: 38741142
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Competing Risk Nomogram for Prediction of Prognosis in Patients With Primary Squamous Cell Thyroid Carcinoma.
    Tian Y; He L; Zhang B; Deng L; Wang J
    Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 1616.